Literature DB >> 19023520

Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.

Chrissa Sioka1, Athanassios P Kyritsis.   

Abstract

Meningioma is a common intracranial tumor, originating from the meninges of the skull or spinal canal. Most meningiomas are benign tumors, however atypical or anaplastic tumors can be found in 6% of cases. Patients with asymptomatic small benign meningiomas can be followed without therapy, but in symptomatic patients complete surgical resection should be performed. For recurrent previously resected tumors re-resection is recommended followed by radiotherapy in selected cases. Antiprogesterone treatment can also be considered in recurrent benign meningiomas. Immunotherapy with interferon-alpha and chemotherapy should be reserved for all cases of recurrent meningiomas (benign, atypical, and malignant) when all the standard therapies have failed or contraindicated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023520     DOI: 10.1007/s11060-008-9734-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.

Authors:  Brian T Ragel; Randy L Jensen; David L Gillespie; Stephen M Prescott; William T Couldwell
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

2.  Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up.

Authors:  H B Newton; S R Scott; C Volpi
Journal:  Br J Neurosurg       Date:  2004-10       Impact factor: 1.596

3.  Mifepristone (RU 486) treatment of meningiomas.

Authors:  S W Lamberts; H L Tanghe; C J Avezaat; R Braakman; R Wijngaarde; J W Koper; H de Jong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-06       Impact factor: 10.154

4.  The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.

Authors:  S E Kaba; F DeMonte; J M Bruner; A P Kyritsis; K A Jaeckle; V Levin; W K Yung
Journal:  Neurosurgery       Date:  1997-02       Impact factor: 4.654

5.  Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.

Authors:  U M Schrell; M G Rittig; M Anders; U H Koch; R Marschalek; F Kiesewetter; R Fahlbusch
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

6.  Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.

Authors:  Brian T Ragel; Randy L Jensen; David L Gillespie; Stephen M Prescott; William T Couldwell
Journal:  J Neurosurg       Date:  2005-09       Impact factor: 5.115

Review 7.  [Somatostatin receptors in meningioma: diagnostic and therapeutic value].

Authors:  R Prat; J Banzo; F J Díaz
Journal:  Rev Neurol       Date:  1997-12       Impact factor: 0.870

8.  Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.

Authors:  J W Koper; R Markstein; C Kohler; D J Kwekkeboom; C J Avezaat; S W Lamberts; J C Reubi
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

9.  Heterogeneity in the expression of markers for drug resistance in brain tumors.

Authors:  U Andersson; B Malmer; A T Bergenheim; T Brännström; R Henriksson
Journal:  Clin Neuropathol       Date:  2004 Jan-Feb       Impact factor: 1.368

10.  Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization.

Authors:  Bernhard Braun; Manfred Lange; Reinhard Oeckler; Margareta M Mueller
Journal:  J Neurooncol       Date:  2004-06       Impact factor: 4.506

View more
  19 in total

1.  WHO grade II and III meningiomas: a study of prognostic factors.

Authors:  Anne Durand; François Labrousse; Anne Jouvet; Luc Bauchet; Michel Kalamaridès; Philippe Menei; Robert Deruty; Jean Jacques Moreau; Michelle Fèvre-Montange; Jacques Guyotat
Journal:  J Neurooncol       Date:  2009-06-27       Impact factor: 4.130

2.  Assessment of the treatment response of spinal meningiomas after radiosurgery focusing on serial MRI findings.

Authors:  Myung Eun Lee; Yoon Joon Hwang; Moon Jun Sohn; Byung Hoon Lee; Su Young Kim
Journal:  Jpn J Radiol       Date:  2015-07-14       Impact factor: 2.374

3.  Is there effective systemic therapy for recurrent surgery- and radiation-refractory meningioma?

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-01

4.  Expression of astrocyte elevated gene-1 (AEG-1) in human meningiomas and its roles in cell proliferation and survival.

Authors:  Kyung-Jae Park; Mi Ok Yu; Na-Hyun Song; Doo-Sik Kong; Dong-Hyuk Park; Yang-Seok Chae; Yong-Gu Chung; Shin-Hyuk Kang
Journal:  J Neurooncol       Date:  2014-09-03       Impact factor: 4.130

5.  Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis.

Authors:  Peter Horak; Adelheid Wöhrer; Marco Hassler; Johannes Hainfellner; Matthias Preusser; Christine Marosi
Journal:  J Neurooncol       Date:  2012-05-20       Impact factor: 4.130

6.  Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2011-11-30       Impact factor: 4.130

Review 7.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

8.  Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.

Authors:  Muhammad O Chohan; Christopher T Ryan; Ranjodh Singh; Ryan M Lanning; Anne S Reiner; Marc K Rosenblum; Viviane Tabar; Philip H Gutin
Journal:  Neurosurgery       Date:  2018-06-01       Impact factor: 4.654

9.  IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-05

10.  Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base.

Authors:  Whitney A Sumner; Arya Amini; Todd C Hankinson; Nicholas K Foreman; Laurie E Gaspar; Brian D Kavanagh; Sana D Karam; Chad G Rusthoven; Arthur K Liu
Journal:  Rep Pract Oncol Radiother       Date:  2017-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.